nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Dyspnoea—Etoposide—urinary bladder cancer	0.00082	0.00082	CcSEcCtD
Meropenem—Somnolence—Etoposide—urinary bladder cancer	0.000818	0.000818	CcSEcCtD
Meropenem—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000817	0.000817	CcSEcCtD
Meropenem—Epistaxis—Methotrexate—urinary bladder cancer	0.000815	0.000815	CcSEcCtD
Meropenem—Vomiting—Thiotepa—urinary bladder cancer	0.000814	0.000814	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—urinary bladder cancer	0.000813	0.000813	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—urinary bladder cancer	0.000809	0.000809	CcSEcCtD
Meropenem—Infestation—Epirubicin—urinary bladder cancer	0.000809	0.000809	CcSEcCtD
Meropenem—Rash—Thiotepa—urinary bladder cancer	0.000808	0.000808	CcSEcCtD
Meropenem—Dermatitis—Thiotepa—urinary bladder cancer	0.000807	0.000807	CcSEcCtD
Meropenem—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000806	0.000806	CcSEcCtD
Meropenem—Headache—Thiotepa—urinary bladder cancer	0.000802	0.000802	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000802	0.000802	CcSEcCtD
Meropenem—Decreased appetite—Etoposide—urinary bladder cancer	0.0008	0.0008	CcSEcCtD
Meropenem—Renal failure—Epirubicin—urinary bladder cancer	0.000795	0.000795	CcSEcCtD
Meropenem—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000794	0.000794	CcSEcCtD
Meropenem—Body temperature increased—Cisplatin—urinary bladder cancer	0.000794	0.000794	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000793	0.000793	CcSEcCtD
Meropenem—Jaundice—Epirubicin—urinary bladder cancer	0.000788	0.000788	CcSEcCtD
Meropenem—Constipation—Etoposide—urinary bladder cancer	0.000787	0.000787	CcSEcCtD
Meropenem—Pain—Etoposide—urinary bladder cancer	0.000787	0.000787	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—urinary bladder cancer	0.000785	0.000785	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—urinary bladder cancer	0.000785	0.000785	CcSEcCtD
Meropenem—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000781	0.000781	CcSEcCtD
Meropenem—Haemoglobin—Methotrexate—urinary bladder cancer	0.00078	0.00078	CcSEcCtD
Meropenem—Haemorrhage—Methotrexate—urinary bladder cancer	0.000776	0.000776	CcSEcCtD
Meropenem—Hepatitis—Methotrexate—urinary bladder cancer	0.000776	0.000776	CcSEcCtD
Meropenem—Sweating—Epirubicin—urinary bladder cancer	0.000775	0.000775	CcSEcCtD
Meropenem—Asthenia—Gemcitabine—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Meropenem—Pharyngitis—Methotrexate—urinary bladder cancer	0.00077	0.00077	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000765	0.000765	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—urinary bladder cancer	0.000763	0.000763	CcSEcCtD
Meropenem—Pruritus—Gemcitabine—urinary bladder cancer	0.000762	0.000762	CcSEcCtD
Meropenem—Nausea—Thiotepa—urinary bladder cancer	0.000761	0.000761	CcSEcCtD
Meropenem—Feeling abnormal—Etoposide—urinary bladder cancer	0.000758	0.000758	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000755	0.000755	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—urinary bladder cancer	0.000753	0.000753	CcSEcCtD
Meropenem—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000752	0.000752	CcSEcCtD
Meropenem—Pruritus—Fluorouracil—urinary bladder cancer	0.00075	0.00075	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000748	0.000748	CcSEcCtD
Meropenem—Infestation—Doxorubicin—urinary bladder cancer	0.000748	0.000748	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Meropenem—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00074	0.00074	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—urinary bladder cancer	0.000739	0.000739	CcSEcCtD
Meropenem—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000737	0.000737	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—urinary bladder cancer	0.000736	0.000736	CcSEcCtD
Meropenem—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000733	0.000733	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000733	0.000733	CcSEcCtD
Meropenem—Urticaria—Etoposide—urinary bladder cancer	0.000731	0.000731	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—urinary bladder cancer	0.00073	0.00073	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—urinary bladder cancer	0.000729	0.000729	CcSEcCtD
Meropenem—Abdominal pain—Etoposide—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Meropenem—Body temperature increased—Etoposide—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—urinary bladder cancer	0.000726	0.000726	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—urinary bladder cancer	0.000726	0.000726	CcSEcCtD
Meropenem—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000725	0.000725	CcSEcCtD
Meropenem—Asthenia—Cisplatin—urinary bladder cancer	0.000721	0.000721	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—urinary bladder cancer	0.000721	0.000721	CcSEcCtD
Meropenem—Sweating—Doxorubicin—urinary bladder cancer	0.000717	0.000717	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000708	0.000708	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—urinary bladder cancer	0.000701	0.000701	CcSEcCtD
Meropenem—Dizziness—Fluorouracil—urinary bladder cancer	0.000701	0.000701	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000698	0.000698	CcSEcCtD
Meropenem—Chills—Methotrexate—urinary bladder cancer	0.000696	0.000696	CcSEcCtD
Meropenem—Diarrhoea—Cisplatin—urinary bladder cancer	0.000687	0.000687	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000686	0.000686	CcSEcCtD
Meropenem—Vomiting—Gemcitabine—urinary bladder cancer	0.000685	0.000685	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—urinary bladder cancer	0.000684	0.000684	CcSEcCtD
Meropenem—Rash—Gemcitabine—urinary bladder cancer	0.000679	0.000679	CcSEcCtD
Meropenem—Dermatitis—Gemcitabine—urinary bladder cancer	0.000679	0.000679	CcSEcCtD
Meropenem—Hypersensitivity—Etoposide—urinary bladder cancer	0.000678	0.000678	CcSEcCtD
Meropenem—Erythema—Methotrexate—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Meropenem—Headache—Gemcitabine—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Meropenem—Vomiting—Fluorouracil—urinary bladder cancer	0.000674	0.000674	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—urinary bladder cancer	0.000672	0.000672	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000672	0.000672	CcSEcCtD
Meropenem—Rash—Fluorouracil—urinary bladder cancer	0.000668	0.000668	CcSEcCtD
Meropenem—Dermatitis—Fluorouracil—urinary bladder cancer	0.000667	0.000667	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000667	0.000667	CcSEcCtD
Meropenem—Headache—Fluorouracil—urinary bladder cancer	0.000664	0.000664	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000662	0.000662	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—urinary bladder cancer	0.000661	0.000661	CcSEcCtD
Meropenem—Asthenia—Etoposide—urinary bladder cancer	0.00066	0.00066	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—urinary bladder cancer	0.000656	0.000656	CcSEcCtD
Meropenem—Back pain—Methotrexate—urinary bladder cancer	0.000653	0.000653	CcSEcCtD
Meropenem—Chills—Epirubicin—urinary bladder cancer	0.000651	0.000651	CcSEcCtD
Meropenem—Pruritus—Etoposide—urinary bladder cancer	0.000651	0.000651	CcSEcCtD
Meropenem—Nausea—Gemcitabine—urinary bladder cancer	0.00064	0.00064	CcSEcCtD
Meropenem—Vomiting—Cisplatin—urinary bladder cancer	0.000639	0.000639	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000635	0.000635	CcSEcCtD
Meropenem—Rash—Cisplatin—urinary bladder cancer	0.000633	0.000633	CcSEcCtD
Meropenem—Dermatitis—Cisplatin—urinary bladder cancer	0.000633	0.000633	CcSEcCtD
Meropenem—Erythema—Epirubicin—urinary bladder cancer	0.000632	0.000632	CcSEcCtD
Meropenem—Diarrhoea—Etoposide—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Meropenem—Nausea—Fluorouracil—urinary bladder cancer	0.000629	0.000629	CcSEcCtD
Meropenem—Anaemia—Methotrexate—urinary bladder cancer	0.000624	0.000624	CcSEcCtD
Meropenem—Flatulence—Epirubicin—urinary bladder cancer	0.000623	0.000623	CcSEcCtD
Meropenem—Tension—Epirubicin—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—urinary bladder cancer	0.000619	0.000619	CcSEcCtD
Meropenem—Nervousness—Epirubicin—urinary bladder cancer	0.000614	0.000614	CcSEcCtD
Meropenem—Back pain—Epirubicin—urinary bladder cancer	0.000611	0.000611	CcSEcCtD
Meropenem—Malaise—Methotrexate—urinary bladder cancer	0.000609	0.000609	CcSEcCtD
Meropenem—Dizziness—Etoposide—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000607	0.000607	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—urinary bladder cancer	0.000604	0.000604	CcSEcCtD
Meropenem—Chills—Doxorubicin—urinary bladder cancer	0.000603	0.000603	CcSEcCtD
Meropenem—Nausea—Cisplatin—urinary bladder cancer	0.000597	0.000597	CcSEcCtD
Meropenem—Cough—Methotrexate—urinary bladder cancer	0.000589	0.000589	CcSEcCtD
Meropenem—Vomiting—Etoposide—urinary bladder cancer	0.000585	0.000585	CcSEcCtD
Meropenem—Erythema—Doxorubicin—urinary bladder cancer	0.000585	0.000585	CcSEcCtD
Meropenem—Anaemia—Epirubicin—urinary bladder cancer	0.000584	0.000584	CcSEcCtD
Meropenem—Agitation—Epirubicin—urinary bladder cancer	0.000581	0.000581	CcSEcCtD
Meropenem—Rash—Etoposide—urinary bladder cancer	0.00058	0.00058	CcSEcCtD
Meropenem—Dermatitis—Etoposide—urinary bladder cancer	0.00058	0.00058	CcSEcCtD
Meropenem—Headache—Etoposide—urinary bladder cancer	0.000576	0.000576	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—urinary bladder cancer	0.000576	0.000576	CcSEcCtD
Meropenem—Chest pain—Methotrexate—urinary bladder cancer	0.000575	0.000575	CcSEcCtD
Meropenem—Tension—Doxorubicin—urinary bladder cancer	0.000574	0.000574	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000573	0.000573	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000571	0.000571	CcSEcCtD
Meropenem—Malaise—Epirubicin—urinary bladder cancer	0.00057	0.00057	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—urinary bladder cancer	0.000568	0.000568	CcSEcCtD
Meropenem—Syncope—Epirubicin—urinary bladder cancer	0.000567	0.000567	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—urinary bladder cancer	0.000566	0.000566	CcSEcCtD
Meropenem—Back pain—Doxorubicin—urinary bladder cancer	0.000566	0.000566	CcSEcCtD
Meropenem—Confusional state—Methotrexate—urinary bladder cancer	0.000556	0.000556	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000555	0.000555	CcSEcCtD
Meropenem—Cough—Epirubicin—urinary bladder cancer	0.000551	0.000551	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000551	0.000551	CcSEcCtD
Meropenem—Infection—Methotrexate—urinary bladder cancer	0.000548	0.000548	CcSEcCtD
Meropenem—Nausea—Etoposide—urinary bladder cancer	0.000547	0.000547	CcSEcCtD
Meropenem—Hypertension—Epirubicin—urinary bladder cancer	0.000546	0.000546	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00054	0.00054	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—urinary bladder cancer	0.00054	0.00054	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00054	0.00054	CcSEcCtD
Meropenem—Chest pain—Epirubicin—urinary bladder cancer	0.000538	0.000538	CcSEcCtD
Meropenem—Agitation—Doxorubicin—urinary bladder cancer	0.000537	0.000537	CcSEcCtD
Meropenem—Anxiety—Epirubicin—urinary bladder cancer	0.000536	0.000536	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—urinary bladder cancer	0.000535	0.000535	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000534	0.000534	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000533	0.000533	CcSEcCtD
Meropenem—Malaise—Doxorubicin—urinary bladder cancer	0.000527	0.000527	CcSEcCtD
Meropenem—Anorexia—Methotrexate—urinary bladder cancer	0.000525	0.000525	CcSEcCtD
Meropenem—Syncope—Doxorubicin—urinary bladder cancer	0.000524	0.000524	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—urinary bladder cancer	0.000523	0.000523	CcSEcCtD
Meropenem—Confusional state—Epirubicin—urinary bladder cancer	0.00052	0.00052	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000516	0.000516	CcSEcCtD
Meropenem—Oedema—Epirubicin—urinary bladder cancer	0.000516	0.000516	CcSEcCtD
Meropenem—Hypotension—Methotrexate—urinary bladder cancer	0.000515	0.000515	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000514	0.000514	CcSEcCtD
Meropenem—Infection—Epirubicin—urinary bladder cancer	0.000512	0.000512	CcSEcCtD
Meropenem—Cough—Doxorubicin—urinary bladder cancer	0.00051	0.00051	CcSEcCtD
Meropenem—Shock—Epirubicin—urinary bladder cancer	0.000507	0.000507	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000506	0.000506	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000505	0.000505	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—urinary bladder cancer	0.000505	0.000505	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—urinary bladder cancer	0.000503	0.000503	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—urinary bladder cancer	0.000501	0.000501	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000499	0.000499	CcSEcCtD
Meropenem—Insomnia—Methotrexate—urinary bladder cancer	0.000498	0.000498	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—urinary bladder cancer	0.000498	0.000498	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—urinary bladder cancer	0.000496	0.000496	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—urinary bladder cancer	0.000495	0.000495	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000494	0.000494	CcSEcCtD
Meropenem—Anorexia—Epirubicin—urinary bladder cancer	0.000492	0.000492	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—urinary bladder cancer	0.000491	0.000491	CcSEcCtD
Meropenem—Somnolence—Methotrexate—urinary bladder cancer	0.00049	0.00049	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—urinary bladder cancer	0.000485	0.000485	CcSEcCtD
Meropenem—Hypotension—Epirubicin—urinary bladder cancer	0.000482	0.000482	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—urinary bladder cancer	0.000481	0.000481	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—urinary bladder cancer	0.000479	0.000479	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000477	0.000477	CcSEcCtD
Meropenem—Oedema—Doxorubicin—urinary bladder cancer	0.000477	0.000477	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000476	0.000476	CcSEcCtD
Meropenem—Infection—Doxorubicin—urinary bladder cancer	0.000474	0.000474	CcSEcCtD
Meropenem—Pain—Methotrexate—urinary bladder cancer	0.000471	0.000471	CcSEcCtD
Meropenem—Shock—Doxorubicin—urinary bladder cancer	0.00047	0.00047	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000468	0.000468	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000467	0.000467	CcSEcCtD
Meropenem—Insomnia—Epirubicin—urinary bladder cancer	0.000466	0.000466	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—urinary bladder cancer	0.000466	0.000466	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—urinary bladder cancer	0.000464	0.000464	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—urinary bladder cancer	0.000463	0.000463	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000461	0.000461	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—urinary bladder cancer	0.00046	0.00046	CcSEcCtD
Meropenem—Somnolence—Epirubicin—urinary bladder cancer	0.000459	0.000459	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—urinary bladder cancer	0.000455	0.000455	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000454	0.000454	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—urinary bladder cancer	0.000454	0.000454	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000451	0.000451	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—urinary bladder cancer	0.000448	0.000448	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—urinary bladder cancer	0.000446	0.000446	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000445	0.000445	CcSEcCtD
Meropenem—Pain—Epirubicin—urinary bladder cancer	0.000441	0.000441	CcSEcCtD
Meropenem—Constipation—Epirubicin—urinary bladder cancer	0.000441	0.000441	CcSEcCtD
Meropenem—Urticaria—Methotrexate—urinary bladder cancer	0.000438	0.000438	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—urinary bladder cancer	0.000436	0.000436	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—urinary bladder cancer	0.000436	0.000436	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—urinary bladder cancer	0.000432	0.000432	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000429	0.000429	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000425	0.000425	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000425	0.000425	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—urinary bladder cancer	0.000424	0.000424	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000422	0.000422	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00042	0.00042	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000415	0.000415	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000412	0.000412	CcSEcCtD
Meropenem—Urticaria—Epirubicin—urinary bladder cancer	0.00041	0.00041	CcSEcCtD
Meropenem—Pain—Doxorubicin—urinary bladder cancer	0.000408	0.000408	CcSEcCtD
Meropenem—Constipation—Doxorubicin—urinary bladder cancer	0.000408	0.000408	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—urinary bladder cancer	0.000408	0.000408	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—urinary bladder cancer	0.000408	0.000408	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000406	0.000406	CcSEcCtD
Meropenem—Asthenia—Methotrexate—urinary bladder cancer	0.000395	0.000395	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000393	0.000393	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00039	0.00039	CcSEcCtD
Meropenem—Pruritus—Methotrexate—urinary bladder cancer	0.00039	0.00039	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00038	0.00038	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—urinary bladder cancer	0.000379	0.000379	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000377	0.000377	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000377	0.000377	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—urinary bladder cancer	0.000377	0.000377	CcSEcCtD
Meropenem—Asthenia—Epirubicin—urinary bladder cancer	0.00037	0.00037	CcSEcCtD
Meropenem—Pruritus—Epirubicin—urinary bladder cancer	0.000365	0.000365	CcSEcCtD
Meropenem—Dizziness—Methotrexate—urinary bladder cancer	0.000364	0.000364	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—urinary bladder cancer	0.000353	0.000353	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000352	0.000352	CcSEcCtD
Meropenem—Vomiting—Methotrexate—urinary bladder cancer	0.00035	0.00035	CcSEcCtD
Meropenem—Rash—Methotrexate—urinary bladder cancer	0.000348	0.000348	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—urinary bladder cancer	0.000347	0.000347	CcSEcCtD
Meropenem—Headache—Methotrexate—urinary bladder cancer	0.000345	0.000345	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—urinary bladder cancer	0.000342	0.000342	CcSEcCtD
Meropenem—Dizziness—Epirubicin—urinary bladder cancer	0.000341	0.000341	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—urinary bladder cancer	0.000338	0.000338	CcSEcCtD
Meropenem—Vomiting—Epirubicin—urinary bladder cancer	0.000328	0.000328	CcSEcCtD
Meropenem—Nausea—Methotrexate—urinary bladder cancer	0.000327	0.000327	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000327	0.000327	CcSEcCtD
Meropenem—Rash—Epirubicin—urinary bladder cancer	0.000325	0.000325	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—urinary bladder cancer	0.000325	0.000325	CcSEcCtD
Meropenem—Headache—Epirubicin—urinary bladder cancer	0.000323	0.000323	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—urinary bladder cancer	0.000316	0.000316	CcSEcCtD
Meropenem—Nausea—Epirubicin—urinary bladder cancer	0.000306	0.000306	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—urinary bladder cancer	0.000303	0.000303	CcSEcCtD
Meropenem—Rash—Doxorubicin—urinary bladder cancer	0.000301	0.000301	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—urinary bladder cancer	0.000301	0.000301	CcSEcCtD
Meropenem—Headache—Doxorubicin—urinary bladder cancer	0.000299	0.000299	CcSEcCtD
Meropenem—Nausea—Doxorubicin—urinary bladder cancer	0.000283	0.000283	CcSEcCtD
